2014
DOI: 10.1242/dev.105981
|View full text |Cite
|
Sign up to set email alerts
|

Small molecule-directed specification of sclerotome-like chondroprogenitors and induction of a somitic chondrogenesis program from embryonic stem cells

Abstract: Pluripotent embryonic stem cells (ESCs) generate rostral paraxial mesoderm-like progeny in 5-6 days of differentiation induced by Wnt3a

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
40
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 38 publications
(40 citation statements)
references
References 44 publications
0
40
0
Order By: Relevance
“…2). understandings for specification and induction processes of chondrogenesis from hESCs [25,36]. Through this, we can further improve the differentiation method and efficiency.…”
Section: Discussionmentioning
confidence: 93%
See 1 more Smart Citation
“…2). understandings for specification and induction processes of chondrogenesis from hESCs [25,36]. Through this, we can further improve the differentiation method and efficiency.…”
Section: Discussionmentioning
confidence: 93%
“…It was also clearly demonstrated the promoters of Wnt signaling and inhibitors of BMP signaling were able to promote the chondrogenic differentiation from ESCs in vitro [23][24][25]. During specification, mESCs and hESCs derived omitic/rostral presomitic mesoderm-like progeny (also known as rostral paraxial mesoderm) was widely confirmed to express platelet-derived growth factor receptor-α (PDGFRα) but not vascular endothelial growth factor receptor-2 (VEGFR2, also known as FLK1 or KDR) [23][24][25][26][27][28][29]. However, the differentiation media used in these studies still contained a small amount of serum, restricting to the future application in clinic.…”
Section: Introductionmentioning
confidence: 99%
“…It has been shown that SCL can be induced from SMs cultured with CDM supplemented with 100 nM SAG, a SHH activator, and 0.6 µM LDN193189, a BMP inhibitor (Zhao et al, 2014) (Fig. 4A).…”
Section: Resultsmentioning
confidence: 99%
“…Within the field of skeletal biology, there is a great interest to use embryonic stem cells (ESCs) to study the molecular basis of different skeletal diseases and as a source from which to derive progenitor cells that could be used in applications of tissue regeneration. Several groups have reported different methodologies to generate chondrocytes and osteoblasts from ESCs (Ahn et al, 2006;Cao et al, 2005;Craft et al, 2013;Tanaka et al, 2009;Tong et al, 2007;Zhao et al, 2014). However, the efficiency by which different protocols work remains unclear.…”
Section: Resultsmentioning
confidence: 99%